Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias (Q36978810)

17 August 2017

1 reference

title

Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias (English)

1 reference

17 August 2017

1 reference

Constantine A Stratakis

series ordinal

object named as

Constantine A Stratakis

1 reference

17 August 2017

Sosipatros A Boikos

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Nature Clinical Practice Endocrinology and Metabolism

17 August 2017

published in

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

748-757

1 reference

Management of the clinically inapparent adrenal mass ("incidentaloma")

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

Role of insulin-like growth factors in embryonic and postnatal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

The Difference in Autofluorescence Features of Lipofuscin between Brain and Adrenal

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Current perspective in the diagnosis and treatment of adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Wilms tumor and the WT1 gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

WT-1 is required for early kidney development

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Gene profiling of human fetal and adult adrenals

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Gene expression profiling of childhood adrenocortical tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

What can we learn from gene expression profiling for adrenal tumor management?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Minireview: transcriptional regulation of adrenocortical development

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Inhibin alpha-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Genetics of the adrenal gland

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

The adrenal life cycle: the fetal and adult cortex and the remaining questions

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Mechanisms of disease: the adrenocorticotropin receptor and disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex)

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Late relapse of adrenocortical carcinoma in Beckwith-Wiedemann syndrome. Clinical, endocrinological and genetic aspects

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Germline TP53 mutations and Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

3',5'-cyclic nucleotide phosphodiesterase 11A: localization in human tissues

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Expression of PDE11A in normal and malignant human tissues

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Phyllodulcin, a constituent of "Amacha", inhibits phosphodiesterase in bovine adrenocortical cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Clinical practice. The incidentally discovered adrenal mass

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0648

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0648

1 reference

17 August 2017

1 reference